Sign in

CIK 0001652130 · Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364785571
Phone
857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
  1. 4 Grant or award Director acquired 5,197 shares (grant or award)
  2. 4 Grant or award Director acquired 5,197 shares (grant or award)
  3. 4 Grant or award Director acquired 5,197 shares (grant or award)
  4. 4 Grant or award Director acquired 5,197 shares (grant or award)
  5. 4 Grant or award Director acquired 2,014 shares (grant or award)
  6. 8-K Event Shareholder vote results
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. 8-K Event Executive or director change
  10. 4 Grant or award Director acquired 7,954 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. DEFA14A Proxy Proxy Materials
  13. DEF 14A Proxy Proxy Statement
  14. 4/A Grant or award Director acquired 1,569 shares (grant or award)
  15. 4 Grant or award EVP, Chief Technical Officer acquired 10,527 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 4/A Derivatives Options or other derivatives
  18. 4 Open-market sale President and CEO sold 2,493 shares at $112.26 ($279,852)
  19. 4/A Derivatives Options or other derivatives
  20. 4/A Derivatives Options or other derivatives

Page 15 of 37 · 725 filings